FDA Adverse Event Malfunction Summary report: N

CMV IGG ELECSYS E2G

MDR report key: 19382489 · Received May 23, 2024

Report

Report Number
1823260-2024-01539
Event Type
Malfunction
Date Received
May 23, 2024
Date of Event
February 23, 2024
Report Date
June 17, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFZ
UDI-DI
07613336198469
PMA / PMN Number
K131605
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE SERIAL NUMBER OF THE E801 ANALYZER IS (B)(6). THE COMPETITOR CMV IGG METHODS USED BY THE CUSTOMER WERE ABBOTT ARCHITECT, VIDAS, AND LIAISON LXL. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THE CMV IGM RESULTS WERE REACTIVE IN CONCORDANCE WITH RESULTS FROM ABBOTT AND DIASORIN, CLEARLY DETECTING THE PRIMARY INFECTION. THE PROVIDED RESULTS OBTAINED WITH SEVERAL METHODS PROVIDE A CLEAR PICTURE OF A YET INCOMPLETE SEROCONVERSION. AN INFLUENCE OF THE DRUG VALACICLOVIR ON THE CMV IGG ASSAY CAN BE RULED OUT. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT ISSUE.

Description of Event or Problem · 0

THE INITIAL REPORTER STATED THEY RECEIVED QUESTIONABLE RESULTS FOR SAMPLES FROM ONE PATIENT TESTED WITH ELECSYS CMV IGG ON A COBAS E 801 ANALYTICAL UNIT. RESULTS FROM FOUR OF THE PATIENT'S SAMPLES DID NOT AGREE WITH RESULTS MEASURED WITH COMPETITOR ASSAYS. RESULTS FOR THE ELECSYS CMV IGG ASSAY BECAME NEGATIVE OVER TIME, BUT NOT RESULTS MEASURED WITH COMPETITOR SYSTEMS. REFER TO THE ATTACHMENT FOR ALL PATIENT DATA. THE RESULTS HIGHLIGHTED IN YELLOW ARE QUESTIONABLE. THE UNITS OF MEASURE USED FOR THE COMPETITOR ASSAYS WERE REQUESTED, BUT NOT PROVIDED. ALL SAMPLES WERE TESTED USING ELECSYS CMV IGG REAGENT LOT NUMBER 743344 (EXPIRATION DATE UNKNOWN) EXCEPT FOR SAMPLE 8, WHICH WAS TESTED USING LOT 772252 (EXPIRATION DATE = 31-JAN-2025).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
583357 CMV IGG ELECSYS E2G CYTOMEGALOVIRUS IMMUNOASSAY LFZ ROCHE DIAGNOSTICS 743344, 77225201 07613336198469

Patients

Seq Age Sex Outcome Treatment
1 NA Female VALACICLOVIR.